FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386508733> ?p ?o ?g. }

• W4386508733 endingPage "324" @default.
• W4386508733 startingPage "312" @default.
• W4386508733 abstract "Goal: The purpose of this quality improvement project was to retrospectively evaluate pharmacist time to clinical surveillance alert intervention before and after implementing a pharmacy-directed alert priority category across a large for-profit United States health system with well-established clinical pharmacy surveillance software integrated into the clinical pharmacy workflow. The findings contributed to a financial evaluation of pharmacist productivity compared with drug spend for pharmacy-directed interventions that included intravenous (IV)-to-oral-conversion and renal dosing opportunities. Methods: A retrospective quality improvement pre-/postanalysis of deidentified, prepopulated clinical surveillance alert data for the preimplementation period of January 1, 2021, through September 30, 2021, was compared with that for the postimplementation period of November 1, 2021, to January 31, 2022, for 169 hospitals. Clinical pharmacist workflow was mapped pre- and postimplementation. The average time to alert intervention was calculated using the mean time in minutes between the alert firing within the software and when the pharmacist reviewed the alert, grouped by hospital, alert status, and priority category. Medications converted from IV to oral were assessed using the clinical surveillance software IV-to-oral calculator. Postimplementation renal dose cost savings were modeled using pharmacist-completed alerts by rule name that indicated a possible dose decrease based on the patient's renal function and current medication. Principal Findings: Time to alert intervention for all completed pharmacist interventions was reduced for high-priority alerts by 32.6 min ( p < .001) and routine-priority alerts by 65.1 min ( p = .147). Alerts that moved to the pharmacy-directed alert priority category resulted in a reduced time to alert intervention of 38.7 min ( p = .003). Normalized average wholesale price (AWP) cost savings from IV-to-oral conversion within 3 days of conversion eligibility were $1,693,600 in the preimplementation period and $1,867,400 in the postimplementation period, a $173,700 increase in cost savings. A total of 7,972 completed postimplementation renal dose adjustments resulted in a modeled AWP normalized cost savings of $1,076,700. Practical Applications: Results indicated that optimizing clinical surveillance software alerts was effective and increased pharmacist productivity. Specifically, creating a pharmacy-directed alert category that pharmacists were able to complete by hospital policy or protocol improved workflow efficiency and increased IV-to-oral medication conversion cost savings. Further study is needed to validate the renal dose–modeled cost savings and address the financial benefits of quality measures to prevent acute kidney injury." @default.
• W4386508733 created "2023-09-08" @default.
• W4386508733 creator A5044225810 @default.
• W4386508733 creator A5047586031 @default.
• W4386508733 creator A5062962064 @default.
• W4386508733 creator A5068670509 @default.
• W4386508733 creator A5092769033 @default.
• W4386508733 creator A5092769034 @default.
• W4386508733 date "2023-09-01" @default.
• W4386508733 modified "2023-10-16" @default.
• W4386508733 title "Impact of Clinical Pharmacy Surveillance on Pharmacy Services: A Quality Improvement Project" @default.
• W4386508733 cites W1601929755 @default.
• W4386508733 cites W1978514915 @default.
• W4386508733 cites W1993053792 @default.
• W4386508733 cites W2008336918 @default.
• W4386508733 cites W2030520800 @default.
• W4386508733 cites W2067827194 @default.
• W4386508733 cites W2077983480 @default.
• W4386508733 cites W2106191825 @default.
• W4386508733 cites W2115441252 @default.
• W4386508733 cites W2534144442 @default.
• W4386508733 cites W2581684376 @default.
• W4386508733 cites W2726551100 @default.
• W4386508733 cites W2891236347 @default.
• W4386508733 cites W2909232534 @default.
• W4386508733 cites W2945826348 @default.
• W4386508733 cites W3013514267 @default.
• W4386508733 cites W3158886314 @default.
• W4386508733 cites W4200171498 @default.
• W4386508733 cites W4226084393 @default.
• W4386508733 doi "https://doi.org/10.1097/jhm-d-22-00176" @default.
• W4386508733 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37678824" @default.
• W4386508733 hasPublicationYear "2023" @default.
• W4386508733 type Work @default.
• W4386508733 citedByCount "0" @default.
• W4386508733 crossrefType "journal-article" @default.
• W4386508733 hasAuthorship W4386508733A5044225810 @default.
• W4386508733 hasAuthorship W4386508733A5047586031 @default.
• W4386508733 hasAuthorship W4386508733A5062962064 @default.
• W4386508733 hasAuthorship W4386508733A5068670509 @default.
• W4386508733 hasAuthorship W4386508733A5092769033 @default.
• W4386508733 hasAuthorship W4386508733A5092769034 @default.
• W4386508733 hasConcept C10446079 @default.
• W4386508733 hasConcept C104863432 @default.
• W4386508733 hasConcept C159110408 @default.
• W4386508733 hasConcept C160735492 @default.
• W4386508733 hasConcept C162324750 @default.
• W4386508733 hasConcept C177212765 @default.
• W4386508733 hasConcept C194828623 @default.
• W4386508733 hasConcept C198783460 @default.
• W4386508733 hasConcept C21547014 @default.
• W4386508733 hasConcept C27415008 @default.
• W4386508733 hasConcept C2776354556 @default.
• W4386508733 hasConcept C2779328685 @default.
• W4386508733 hasConcept C2779457091 @default.
• W4386508733 hasConcept C41008148 @default.
• W4386508733 hasConcept C50522688 @default.
• W4386508733 hasConcept C512399662 @default.
• W4386508733 hasConcept C545542383 @default.
• W4386508733 hasConcept C71405471 @default.
• W4386508733 hasConcept C71924100 @default.
• W4386508733 hasConcept C77088390 @default.
• W4386508733 hasConceptScore W4386508733C10446079 @default.
• W4386508733 hasConceptScore W4386508733C104863432 @default.
• W4386508733 hasConceptScore W4386508733C159110408 @default.
• W4386508733 hasConceptScore W4386508733C160735492 @default.
• W4386508733 hasConceptScore W4386508733C162324750 @default.
• W4386508733 hasConceptScore W4386508733C177212765 @default.
• W4386508733 hasConceptScore W4386508733C194828623 @default.
• W4386508733 hasConceptScore W4386508733C198783460 @default.
• W4386508733 hasConceptScore W4386508733C21547014 @default.
• W4386508733 hasConceptScore W4386508733C27415008 @default.
• W4386508733 hasConceptScore W4386508733C2776354556 @default.
• W4386508733 hasConceptScore W4386508733C2779328685 @default.
• W4386508733 hasConceptScore W4386508733C2779457091 @default.
• W4386508733 hasConceptScore W4386508733C41008148 @default.
• W4386508733 hasConceptScore W4386508733C50522688 @default.
• W4386508733 hasConceptScore W4386508733C512399662 @default.
• W4386508733 hasConceptScore W4386508733C545542383 @default.
• W4386508733 hasConceptScore W4386508733C71405471 @default.
• W4386508733 hasConceptScore W4386508733C71924100 @default.
• W4386508733 hasConceptScore W4386508733C77088390 @default.
• W4386508733 hasIssue "5" @default.
• W4386508733 hasLocation W43865087331 @default.
• W4386508733 hasLocation W43865087332 @default.
• W4386508733 hasOpenAccess W4386508733 @default.
• W4386508733 hasPrimaryLocation W43865087331 @default.
• W4386508733 hasRelatedWork W103050526 @default.
• W4386508733 hasRelatedWork W1569488152 @default.
• W4386508733 hasRelatedWork W2035672645 @default.
• W4386508733 hasRelatedWork W2048293209 @default.
• W4386508733 hasRelatedWork W2541596473 @default.
• W4386508733 hasRelatedWork W2763852676 @default.
• W4386508733 hasRelatedWork W2958674658 @default.
• W4386508733 hasRelatedWork W3030737585 @default.
• W4386508733 hasRelatedWork W3197219637 @default.
• W4386508733 hasRelatedWork W4285380062 @default.
• W4386508733 hasVolume "68" @default.

• next